MYMD PHARMACEUTICALS INC's ticker is and the CUSIP is 62856X102. A total of 49 filers reported holding MYMD PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 4.52 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $16,069 | -75.0% | 62,116 | -42.8% | 0.00% | – |
| Q3 2023 | $64,302 | +0.1% | 108,619 | +153.5% | 0.00% | – |
| Q2 2023 | $64,268 | +81251.9% | 42,845 | -37.3% | 0.00% | – |
| Q4 2022 | $79 | -99.8% | 68,312 | +380.7% | 0.00% | – |
| Q3 2022 | $37,000 | -90.1% | 14,211 | -76.9% | 0.00% | – |
| Q4 2021 | $373,000 | – | 61,470 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Praetorian Wealth Management, Inc. | 200,000 | $118,400 | 0.04% |
| Atlas Brown,Inc. | 43,500 | $25,752 | 0.01% |
| Taylor & Morgan Wealth Management, LLC | 16,086 | $9,523 | 0.01% |
| Cambria Investment Management, L.P. | 171,570 | $101,569 | 0.01% |
| Fidelis Capital Partners, LLC | 38,590 | $22,845 | 0.01% |
| Corundum Group, Inc. | 19,600 | $11,603 | 0.01% |
| WALLED LAKE PLANNING & WEALTH MANAGEMENT, LLC | 14,000 | $8,288 | 0.00% |
| Bridgecreek Investment Management, LLC | 30,000 | $17,760 | 0.00% |
| XTX Topco Ltd | 39,544 | $23,410 | 0.00% |
| NWAM LLC | 40,000 | $23,680 | 0.00% |